• Adaptogenic tonic herb used in treating low energy states and fatigue. Improves vitality, restores normal sleep patterns, improves heart function. Helps recovery from long-term over-exertion from sport and physical stress. Supports recovery after chemotherapy and radiotherapy and during convalescence. May relieve hypertension, rheumatism, fibromyalgia, depression and Alzheimer’s. Supports recovery from drug addiction. Acts as hormonal regulator – useful in weight management. Siberian ginseng’s action is circulatory and as an immune stimulant. It has a detoxifying anti-inflammatory action. 400mg, 60 capsules.
  • FLORA FORCE® TURMERYNNE® capsules with turmeric, cayenne and black pepper, provide antioxidants for the maintenance of good health, and may reduce inflammation. Preliminary research suggests that turmeric (Curcuma longa) and its active constituent, curcumin, may have antioxidant effects. These help to scavenge free radicals. Curcumin also has an anti-inflammatory action. The major active constituent in Cayenne (Capsicum minimum) is capsaicin. Various studies suggest that Capsicum minimum and capsaicin have antioxidant effects and decrease inflammation. Piperine, the active constituent found in Black Pepper (Piper nigrum) increases the oral absorption and bio-availability of other substances. Avoid taking TURMERYNNE® capsules if you are pregnant or breastfeeding.

    PATIENT INFORMATION LEAFLET

    Information for the Patient about FLORA FORCE® TURMERYNNE® Capsules

    Information currently undergoing review, please refer to Professional Information below.
    TURMERYNNE® Capsules Western herbal medicine This medicine has not been evaluated by the Medicines Control Council.  This medicine is not intended to diagnose, treat, cure or prevent any disease. SCHEDULING STATUS: Not Scheduled PROPRIETARY NAME (AND DOSAGE FORM): TURMERYNNE® Capsules COMPOSITION: Each TURMERYNNE® capsule contains:
    ACTIVE INGREDIENT QUANTITY
    Curcuma longa rhizome powder 215 mg
    Capsicum minimum fruit powder 215 mg
    Piper nigrum fruit powder 20 mg
    Inactive ingredients: vegetable capsules TURMERYNNE® capsules are free from sugar and lactose. PHARMACOLOGICAL CLASSIFICATION: D 40.1 Complementary medicine not otherwise specified – Discipline specific traditional claim PHARMACOLOGICAL ACTION: Pharmacodynamic properties:

    The major active constituents in Curcuma longa are curcuminoids including curcumin.  Preliminary research suggests that turmeric and its constituent curcumin may have anti-oxidant effects.  Both turmeric and its constituents have been found to scavenge free radicals and phenolic oxidants and decrease levels of reactive oxygen species.

    Curcumin has anti-inflammatory activity, possibly by inhibiting cyclooxygenase-2 (COX-s), prostaglandins, leukotrienes and other cytokines involved in pro-inflammatory signalling pathways.

    The major active constituent in Capsicum minimum is capsaicin.  Various studies suggest that Capsicum minimum and capsaicin have anti-oxidant effects and decrease inflammation.

    The active constituent, piperine, found in Piper nigrum increases the oral absorption and bio-availability of other substances.

    INDICATIONS:

    TURMERYNNE® capsules provide anti-oxidants for the maintenance of good health, and may reduce inflammation.

    CONTRA-INDICATIONS:

    TURMERYNNE® capsules are contra-indicated in patients with:

    • A hypersensitivity to any of the ingredients in TURMERYNNE®
    • Biliary obstruction (bile duct obstruction and gallstones) (see “WARNINGS AND SPECIAL PRECAUTIONS”).
    • Bleeding disorders (see “WARNING AND SPECIAL PRECAUTIONS”).
    • Diabetes (see “WARNINGS AND SPECIAL PRECAUTIONS”).
    • Hypertension (see “WARNINGS AND SPECIAL PRECAUTIONS”).
    • Gastro-oesophageal reflux disease.
    • Infertility.
    • Iron deficiency (see “WARNINGS AND SPECIAL PRECAUTIONS”).
    • Surgery (see “WARNINGS AND SPECIAL PRECUATIONS”).
    • Pregnancy and lactation (see “PREGNACY AND LACTATION”).
    WARNINGS AND SPECIAL PRECAUTIONS:

    TURMERYNNE® capsules should be used with care in patients with cholelithiasis (gallstones) and should only be used after consultation with a physician (see “CONTRA-INDICATIONS”).

    When starting, or stopping treatment with Capsicum spp.  and Curcuma longa containing products, including TURMERYNNE® capsules, patients with bleeding disorders should have increased monitoring of their INR (International Normalised Ratio) levels (see “CONTRA-INDICATIONS”).

    TURMERYNNE® capsules should be used with care in patients with diabetes as curcumin and Capsicum spp. may decrease blood sugar levels.  Diabetic patients should monitor their blood sugar levels when taking TURMERYNNE® capsules (see “CONTRA-INDICATIONS”).

    TURMERYNNE® capsules should be used with care in patients with hypertension.  Theoretically Capsicum spp. may increase blood pressure. 

    TURMERYNNE® capsule should be used with caution in patients with iron deficiency.  Patient should monitor their iron levels (see “CONTRA-INDICATIONS”).

    TURMERYNNE® capsules should be used with care in patients undergoing surgery.  Patients should discontinue use at least 2 weeks before elective surgical procedures (see “CONTRA-INDICATIONS”).

    TURMERYNNE® capsules should be used with care in patients with hormone-sensitive cancers.  Theoretically, turmeric might have mild estrogenic effects. Until more is known, advise women with hormone-sensitive conditions to use turmeric cautiously.

    When starting, or stopping treatment with capsicum and turmeric containing products, including TURMERYNNE® capsules, patients taking warfarin (or other coumarin anti-coagulants) should have increased monitoring of their INR (International Normalised Ratio) levels (see “INTERACTIONS”).

    TURMERYNNE® capsules should be used with care in patients taking sedative medications, including midazolam, as it may increase its sedative effects (see “INTERACTIONS”).

    The use of TURMERYNNE® capsules in children and adolescents under 18 years of age is not recommended due to lack of adequate data (see “DOSAGE AND DIRECTIONS FOR USE”).

    Effects on the ability to drive or use machinery: No studies on the effect of TURMERYNNE® capsules on the ability to drive or operate machines have been performed.  It is unlikely that TURMERYNNE® capsules will affect the ability to drive or operate machines.

    INTERACTIONS:

    The herbs in TURMERYNNE® capsules may interact with the following medicines:

    • Theophylline: Capsicum and piperine may enhance theophylline absorption.
    • Beta blockers: curcumin may decrease or increase absorption.  Piperine may increase absorption of propranolol.
    • Sulfasalazine: Curcuma longa might increase absorption of sulfasalazine.
    • Oestrogen: Curcuma longa might decrease the effects of oestrogen
    • Lithium: Piper nigrum may increase levels of lithium.
    • Rifampin: piperine might increase absorption.
    • Norfloxacin: Curcuma longa might increase levels

    Advise patients to take any of the above-mentioned medicines at least 2 hours before or after TURMERYNNE® capsules (see “DOSAGE AND DIRECTIONS FOR USE”).

    Capsicum spp. and Curcuma longa, as in TURMERYNNE® capsules, may potentially increase the effect of oral anti-coagulants and anti-platelet drugs (e.g. warfarin, aspirin, clopidogrel, dalteparin, enoxaparin, heparin) when taken concomitantly.  Patients taking anti-coagulants or anti-platelet medicines should have their INR levels monitored more frequently when taking TURMERYNNE® capsules (see “WARNINGS AND SPECIAL PRECAUTIONS”).

    Piper nigrum, as in TURMERYNNE® capsules, may increase the effect of medications for epilepsy when taken concomitantly.  Patients taking these medications should use TURMERYNNE® capsules with caution and be monitored closely.  Some of these medications include carbamazepine and phenytoin.

    Theoretically, Capsicum spp. and Curcuma longa, as in TURMERYNNE® capsules, may enhance the blood glucose lowering effects of anti-diabetic medicines.  Patients on anti-diabetic medicines should monitor their glucose levels closely when taking TURMERYNNE® capsules.

    Theoretically, Piper nigrum and Curcuma longa might increase levels of p-glycoprotein substrates.  Some of these medicines include chemotherapeutic agents, anti-fungals, protease inhibitors, H2 agonists, calcium channel blockers, digoxin, corticosteroids, erythromycin, cisapride, fexofenadine, cyclosporine, loperamide and quinidine.

    Curcuma longa, as in TURMERYNNE® capsules, may increase the sedative effects of midazolam.  Patients taking midazolam should use TURMERYNNE® capsule with caution (see “WARNINGS AND SPECIAL PRECAUTIONS”).

    Piperine increases the bio-availability of curcumin in Turmeric. This may increase the potential of curcumin to interacting with other medicines.

    There is some evidence that Curcuma longa and/or curcumin, Capsicum spp. and Piper nigrum may interact with CYP3A4 enzymes and increase bioavailability of medicines metabolised by cytochrome P450 isoenzymes CYP3A4.  Patients taking medicines metabolised by these enzymes should use TURMERYNNE® capsules cautiously.  These medicines include calcium channel blockers, chemotherapeutic agents, anti-fungals, glucocorticoids, alfentanil, cisapride, fentanyl, lidocaine, losartan, fluoxetine, omeprazole, ondansetron and fexofenadine.

    There is some evidence that Curcuma longa may interact with CYP1A2 enzymes and increase the bio-availability of medicines metabolised by cytochrome P450 1A2 isoenzymes CYP1A2.  Patients taking medicines metabolised by these enzymes should use TURMERYNNE® capsules cautiously.  Some of these medicines include clozapine, fluvoxamine, haloperidol, imipramine, olanzapine, pentazocine, propranolol and zolmitriptan.

    There is some evidence that Curcuma longa and Piper nigrum, as in TURMERYNNE® capsules, may increase levels of certain anti-neoplastic agents such as docetaxel, paclitaxel, etoposide, vinblastine and vincristine.

    Theoretically, Curcuma longa may decrease the absorption of iron.  Patients taking iron should monitor their iron levels when taking TURMERYNNE® capsules.

    PREGNANCY AND LACTATION:

    The safety and efficacy of TURMERYNNE® capsules during pregnancy and lactation have not been established.  Capsules should therefore not be taken during pregnancy and lactation.

    DOSAGE AND DIRECTIONS FOR USE:

    The recommended daily dose should not be exceeded. Do not tamper with capsule.

    Adults (18 years and older): Take 2 capsules twice daily with meals or as prescribed.

    Children (under 18 years of age): Not recommended for use (see “WARNINGS AND SPECIAL PRECAUTIONS”).

    Theophylline, beta-blockers, sulfasalazine, oestrogen, lithium, rifampicin and norfloxacin must be taken at least 2 hours before or after TURMERYNNE® capsules (see “INTERACTIONS”).

    SIDE-EFFECS:

    The following side-effects may occur with the use of TURMERYNNE® capsules.

    Endocrine disorders: Frequency unknown:         Reduced blood glucose, increase plasma insulin.

    Psychiatric disorders: Frequency unknown:         Addiction.

    Nervous system disorders: Frequency unknown:         Dizziness, hyperalgesia, vertigo.

    Vascular disorders: Frequency unknown:         Increased bleeding, myocardial infarct, hypertension and tachycardia.

    Gastrointestinal disorders: Frequency unknown:         Gastro-intestinal irritation, mouth and throat irritation, stomach discomfort, dyspepsia, diarrhoea, constipation, yellow hard stools, abdominal distention, gastro-oesophageal reflux, nausea, flatulence, ulcer aggravation, vomiting and liver damage.

    Skin and subcutaneous disorders: Frequency unknown:         Photosensitivity, pruritus, oedema.

    Renal and urinary disorders: Frequency unknown:         Kidney damage.

    KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENTS:

    The following symptoms may be experienced in the event of an overdose: Tachycardia, hypertension, hypertensive crisis and myocardial infarct. Contact a poison control centre in area.

    IDENTIFICATION:

    Clear size 0 all vegetable capsule containing dark orange herbal powder.

    PRESENTATION:

    90 Capsules packed in a 125ml amber glass bottle with light gold/mustard screw cap and safety seal insert.

    STORAGE INSTRUCTIONS:

    Store at or below 25 ºC in a dry place. Protect from light. KEEP OUT OF REACH OF CHILDREN.

    REGISTRATION NUMBER:

    To be allocated.

    NAME AND BUSINESS ADDRESS OF THE HOLDER OF THE CERTIFICATE OF REGISTRATION:

    Flora Force Heath Products (Pty) Ltd. Unit 3 Regent Park, Bell Crescent, Westlake, Cape Town

    DATE OF PUBLICATION:

    To be allocated.

    Herb Library

    Explore our Herb Library for additional information on traditional uses of herbs.

    Related blog articles

    Learn more about antioxidants in our blog ‘What are antioxidants and why do we need them?’
  • FLORA FORCE® TURMERIC capsules provide antioxidants for the maintenance of good health. Preliminary research suggests that turmeric and its constituent curcumin may have antioxidant effects. The capsules are free from sugar and lactose. Avoid taking FLORA FORCE® TURMERIC capsules if you are pregnant or breastfeeding.

    PATIENT INFORMATION LEAFLET

    Information for the Patient about FLORA FORCE® TURMERIC Capsules

    Information currently undergoing review, please refer to Professional Information below.
    FLORA FORCE® TURMERIC Capsules Western herbal medicine FLORA FORCE® TURMERIC capsules has not been evaluated by the Medicines Control Council. This medicine is not intended to diagnose, treat, cure or prevent any disease. SCHEDULING STATUS: Not Scheduled PROPRIETARY NAME (AND DOSAGE FORM): FLORA FORCE® TURMERIC Capsules COMPOSITION: Each FLORA FORCE® TURMERIC capsule contains:
    ACTIVE INGREDIENT QUANTITY
    Curcuma longa rhizome powder 500 mg
    Inactive ingredients: vegetable capsules FLORA FORCE® TURMERIC capsules are free from sugar and lactose. PHARMACOLOGICAL CLASSIFICATION: D 40.1 Complementary medicine not otherwise specified - Discipline specific traditional claim PHARMACOLOGICAL ACTION: Pharmacodynamic properties:

    The major active constituents in Curcuma longa are curcuminoids including curcumin. Preliminary research suggests that turmeric and its constituent curcumin may have antioxidant effects. Both turmeric and its constituents have been found to scavenge free radicals and phenolic oxidants and decrease levels of reactive oxygen species.

    INDICATIONS:

    FLORA FORCE® TURMERIC capsules provide antioxidants for the maintenance of good health.

    CONTRA-INDICATIONS:

    FLORA FORCE® TURMERIC capsules are contra-indicated in patients with:

    • A hypersensitivity to Curcuma longa.
    • Biliary obstruction (bile duct obstruction and gallstones) (see “WARNINGS AND SPECIAL PRECAUTIONS”).
    • Bleeding disorders (see “WARNINGS AND SPECIAL PRECAUTIONS”).
    • Diabetes (see “WARNING AND SPECIAL PRECAUTIONS”).
    • Gastroesophageal reflux disease.
    • Hormone sensitive cancers/conditions
    • Infertility
    • Iron deficiency (see “WARNING AND SPECIAL PRECAUTIONS”)
    • Surgery (see “WARNING AND SPECIAL PRECAUTIONS”)
    WARNINGS AND SPECIAL PRECAUTIONS:

    FLORA FORCE® TURMERIC capsules should be used with care in patients with cholelithiasis (gallstones) and should only be used after consultation with a physician (see “CONTRA-INDICATIONS”).

    When starting, or stopping treatment with turmeric containing products, including FLORA FORCE® TURMERIC capsules, patients with bleeding disorders should have increased monitoring of their INR (International Normalised Ratio) levels (see "CONTRA-INDICATIONS").

    FLORA FORCE® TURMERIC capsules should be used with care in patients with diabetes as curcumin may decrease blood sugar levels. Diabetic patients should monitor their blood sugar levels when taking FLORA FORCE® TURMERIC capsules (see "CONTRA-INDICATIONS").

    FLORA FORCE® TURMERIC capsules should be used with caution in patients with iron deficiency. Patient should monitor their iron levels (see "CONTRAINDICATIONS").

    FLORA FORCE® TURMERIC capsules should be used with care in patients undergoing surgery. Patients should discontinue use at least 2 weeks before elective surgical procedures (see "CONTRAINDICATIONS")

    When starting, or stopping treatment with turmeric containing products, including FLORA FORCE® TURMERIC capsules, patients taking warfarin (or other coumarin anticoagulants) should have increased monitoring of their INR (International Normalised Ratio) levels (see "INTERACTIONS").

    FLORA FORCE® TURMERIC capsules should be used with care in patients taking sedative medications, including Midazolam, as it may increase its sedative effects (see "INTERACTIONS").

    Vitamins and minerals obtained from other sources should be taken into consideration when taking FLORA FORCE® TURMERIC capsules.

    Effects on the ability to drive or use machinery: No studies on the effect of FLORA FORCE® TURMERIC capsules on the ability to drive or operate machines have been performed. It is unlikely that FLORA FORCE® TURMERIC capsules capsules will affect the ability to drive or operate machines.

    INTERACTIONS:

    FLORA FORCE® TURMERIC capsules may interact with the following medicines:.

    • Beta blockers: curcumin may decrease the absorption of talinolol and may increase the absorption of celiprolol.
    • Sulfasalazine: Curcuma longa might increase absorption of sulfasalazine.
    • Oestrogen: Curcuma longa might decrease the effects of oestrogen
    • Norfloxacin: Curcuma longa might increase levels

    The dose of the above medications may need to be adjusted when taken in conjunction with FLORA FORCE® TURMERIC capsules.

    Advise patients to take any of the above-mentioned medicines at least 2 hours before or after FLORA FORCE® TURMERIC capsules.

    Curcuma longa, as in FLORA FORCE® TURMERIC capsules, may potentially increase the effect of oral anti-coagulants and anti-platelet drugs (e.g. warfarin, aspirin, clopidogrel, dalteparin, enoxaparin, heparin, ticlopidine) when taken in conjunction. Patients taking anti-coagulants or antiplatelet medicines should have their INR levels monitored more frequently when taking FLORA FORCE® TURMERIC capsules (see "WARNINGS AND SPECIAL PRECAUTIONS").

    Theoretically, Curcuma longa, as in FLORA FORCE® TURMERIC capsules, may enhance the blood glucose lowering effects of antidiabetic medicines. Patients on antidiabetic medicines should monitor their glucose levels closely when taking FLORA FORCE® TURMERIC capsules (see "WARNINGS AND SPECIAL PRECAUTIONS")

    `Theoretically, Curcuma longa, as in FLORA FORCE® TURMERIC capsules, might increase levels of p-glycoprotein substrates. Some of these medicines include chemotherapeutic agents, antifungals, protease inhibitors, H2 agonists, calcium channel blockers, digoxin, corticosteroids, erythromycin, cisapride, fexofenadine, cyclosporine, loperamide and quinidine.

    Curcuma longa, as in FLORA FORCE® TURMERIC capsules, may increase the sedative effects of Midazolam. Patients taking Midazolam should use FLORA FORCE® TURMERIC capsules with caution (see "WARNINGS AND SPECIAL PRECAUTIONS").

    There is some evidence that Curcuma longa and/or curcumin may interact with CYP3A4 enzymes and increase bioavailability of medicines metabolised by cytochrome P450 isoenzymes CYP3A4. Patients taking medicines metabolised by these enzymes should use FLORA FORCE® TURMERIC capsules cautiously. Some of these medicines include calcium channel blockers, chemotherapeutic agents, antifungals, glucocorticoids, alfentanil, cisapride, fentanyl, lidocaine, losartan, fluoxetine, omeprazole, ondansetron and fexofenadine.

    There is some evidence that Curcuma longa may interact with CYP1A2 enzymes and increase the bioavailability of medicines metabolised by cytochrome P450 1A2 isoenzymes CYP1A2. Patients taking medicines metabolised by these enzymes should use FLORA FORCE® TURMERIC capsules cautiously. Some of these medicines include clozapine, fluvoxamine, haloperidol, imipramine, olanzapine, pentazocine, propranolol and zolmitriptan.

    There is some evidence that Curcuma longa as in FLORA FORCE® TURMERIC capsules, may increase levels of certain antineoplastic agents. Some of these include docetaxel, paclitaxel, etoposide, vinblastine, vincristine and vindesine. Theoretically, Curcuma longa may decrease the absorption of iron. Patients taking iron should monitor their iron levels when taking FLORA FORCE® TURMERIC capsules.

    PREGNANCY AND LACTATION:

    The safety and efficacy of FLORA FORCE® TURMERIC capsules during pregnancy and lactation have not been established. FLORA FORCE® TURMERIC capsules should therefore not be taken during pregnancy and lactation.

    DOSAGE AND DIRECTIONS FOR USE:

    The recommended daily dose should not be exceeded.

    Adults (18 years and older): Take 2 capsules twice daily with meals or as prescribed.

    Children (under 18 years of age): Not recommended for use (see “WARNINGS AND SPECIAL PRECAUTIONS”).

    SIDE-EFFECS:

    The following side-effects may occur with the use of FLORA FORCE® TURMERICcapsules.

    Psychiatric disorders: Frequency unknown: Giddiness

    Nervous system disorders: Frequency unknown: Vertigo

    Gastrointestinal disorders: Frequency unknown: Constipation, flatulence and yellow, hard stools, nausea and vomiting, diarrhoea or loose stool, dyspepsia, gastritis, distension and gastroesophageal reflux disease, abdominal fullness and pain, epigastric burning and tongue staining.

    Skin and subcutaneous disorders: Frequency unknown: Pruritus, pitting oedema, photosensitivity.

    Renal and urinary disorders: Frequency unknown: Diuresis

    Reproductive system and breast disorders: Frequency unknown: Increased menstrual bleeding

      KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENTS:

    None known. Contact a poison control centre in area.

    IDENTIFICATION:

    Clear size 0 all vegetable capsule containing dark yellow herbal powder.

    PRESENTATION:

    60 Capsules packed into 125ml amber glass bottle with light green screw cap and safety seal insert.

    STORAGE INSTRUCTIONS:

    Store at or below 25 ºC in a dry place. Protect from light. KEEP OUT OF REACH OF CHILDREN.

    REGISTRATION NUMBER:

    To be allocated.

    NAME AND BUSINESS ADDRESS OF THE HOLDER OF THE CERTIFICATE OF REGISTRATION:

    Flora Force Heath Products (Pty) Ltd. Unit 3 Regent Park, Bell Crescent, Westlake, Cape Town

    DATE OF PUBLICATION:

    21/11/2016

    Herb Library

    Explore our Herb Library for additional information on traditional uses of herbs.

    Related blog articles

    Read more about anti-oxidants in our blog ‘What are anti-oxidants and why do we need them?’.
  • Anti-ageing properties prevent degenerative disease by reducing free radicals. The anti-oxidant properties of the catechins in green tea reduce free radicals and have a detoxifying action. The flavonoids have an anti-inflammatory and protective action against cardiovascular diseases and strengthen blood vessels. Used in weight management. 400mg, 90 capsules.